Hong Kong-based biotech firm WuXi Biologics has signed a 10-year lease for 7 Clarke Drive in Cranbury, New Jersey, taking the entire 68,000-square-foot clinical manufacturing facility. WuXi Biologics was represented by Robert Ryan and John Buckley, both executive vice presidents with JLL.
“WuXi Biologics continues to develop its global supply chain network,” said Ryan. “The Cranbury location offers the leading global CDMO tremendous access to New Jersey’s highly trained workforce and leading scientists’ pool.”
Located near Princeton, the facility comprises 68,000 square feet of research and development laboratory, biologics manufacturing, and office space. The tenant will equip the building with process development and quality control laboratories and other supporting functions. The 7 Clarke Drive clinical manufacturing facility was constructed in 1998 and is located within Cedar Brook Corporate Center, a 1.2 million-square-foot office and technology park on 150 acres in Cranbury.
This is the third location for the company in the United States. WuXi Biologics is building a new facility in Worcester, Massachusetts, in addition to completing a lease of 33,000 square feet for a development laboratory in King of Prussia, Pennsylvania.